Moderna takes one more step along the high-wire act of Covid-19 vaccine work, offering markers of success for the most vulnerable age group
One of the big questions facing any of the Covid-19 vaccines is whether or not they can protect the elderly — the most vulnerable group facing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
